An in vitro study of epoetin beta intravenous injection site at the end of hemodialysis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 20542102)

Published in Int J Pharm on June 11, 2010

Authors

Fabien Xuereb1, Valérie de Précigout, Christian Combe, Gilles Sinnasse-Raymond, Marie-Claude Saux, Dominique Breilh

Author Affiliations

1: EA 2968 Laboratoire de Pharmacocinétique et de Pharmacie Clinique, Université Victor Segalen Bordeaux 2, 146 Rue Léo-Saignat, 33076 Bordeaux, Cedex, France. fabien.xuereb@chu-bordeaux.fr

Articles by these authors

Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 3.37

Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011. Clin Infect Dis (2012) 2.71

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med (2005) 2.61

Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia. Crit Care Med (2003) 2.40

Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int (2002) 2.24

Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol (2010) 2.22

In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology (2004) 2.22

Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol (2007) 2.18

Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects. Nephrol Dial Transplant (2007) 2.17

Fractional excretion of urea as a diagnostic index in acute kidney injury in intensive care patients. J Crit Care (2012) 2.09

Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia. Crit Care Med (2008) 1.75

Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients. Intensive Care Med (2007) 1.64

Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal (2009) 1.63

Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging (2003) 1.54

Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients. Antimicrob Agents Chemother (2002) 1.54

Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern Study. Hemodial Int (2014) 1.43

The associations of social support and other psychosocial factors with mortality and quality of life in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol (2010) 1.37

Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study). AIDS (2004) 1.35

Supersonic shear wave elastography of in vivo pig kidney: influence of blood pressure, urinary pressure and tissue anisotropy. Ultrasound Med Biol (2012) 1.33

Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia. Intensive Care Med (2004) 1.23

Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group. Diabetes Care (2007) 1.21

C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol (2011) 1.21

Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study). Antivir Ther (2006) 1.19

MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology (2006) 1.18

Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis (2005) 1.15

Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism (2006) 1.14

Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int (2003) 1.14

HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis (2005) 1.12

Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study). AIDS (2002) 1.11

Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum (2007) 1.09

HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. J Antimicrob Chemother (2010) 1.08

Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia. Intensive Care Med (2006) 1.06

Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia. J Antimicrob Chemother (2012) 1.06

Doppler resistive index to reflect regulation of renal vascular tone during sepsis and acute kidney injury. Crit Care (2012) 1.04

USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans. Eur Radiol (2007) 1.03

Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. Kidney Int (2002) 1.02

Protonation equilibrium and lipophilicity of moxifloxacin. J Pharm Biomed Anal (2005) 1.02

Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.01

The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects. Nephrol Dial Transplant (2006) 0.99

Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia. Intensive Care Med (2004) 0.97

New predictive equations improve monitoring of kidney function in patients with diabetes. Diabetes Care (2007) 0.97

Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. BMC Nephrol (2010) 0.96

Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort. J Antimicrob Chemother (2009) 0.96

Site specific alterations of adipose tissue mitochondria in 3'-azido-3'-deoxythymidine (AZT)-treated rats: an early stage in lipodystrophy? Biochem Pharmacol (2005) 0.96

Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients. Antimicrob Agents Chemother (2007) 0.94

Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model. Antimicrob Agents Chemother (2002) 0.94

Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.93

Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother (2004) 0.90

Long-term outcome on renal replacement therapy in patients who previously received a keto acid-supplemented very-low-protein diet. Am J Clin Nutr (2009) 0.90

Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin J Am Soc Nephrol (2013) 0.90

Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study). Antivir Ther (2008) 0.89

Immunoadsorption in patients with haemolytic uraemic syndrome. Lancet (2012) 0.89

Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia. Intensive Care Med (2006) 0.89

Nutritional status in patients with diabetes and chronic kidney disease: a prospective study. Am J Clin Nutr (2007) 0.88

IQGAP1 interacts with components of the slit diaphragm complex in podocytes and is involved in podocyte migration and permeability in vitro. PLoS One (2012) 0.88

Glucose control influences glomerular filtration rate and its prediction in diabetic subjects. Diabetes Care (2006) 0.87

Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats. Eur Radiol (2011) 0.86

Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrob Agents Chemother (2006) 0.86

Early evolution of nutritional status and body composition after kidney transplantation. Am J Kidney Dis (2002) 0.86

Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia. Crit Care Med (2005) 0.86

Haemodialysis prescription, adherence and nutritional indicators in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 0.86

Nutritional status partly explains the overestimation of GFR by the Cockcroft and Gault formula in diabetic subjects with severe chronic renal failure. Nephrol Dial Transplant (2006) 0.85

Carbapenems. J Chemother (2013) 0.85

Vegetarianism: advantages and drawbacks in patients with chronic kidney diseases. J Ren Nutr (2013) 0.84

A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study. Intern Emerg Med (2011) 0.84

Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int (2002) 0.84

Cytoskeletal reorganization by mycophenolic acid alters mesangial cell migration and contractility. Hypertension (2003) 0.83

Considerations regarding the management of hyponatraemia secondary to SIADH. Best Pract Res Clin Endocrinol Metab (2012) 0.83

Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab. Nephrol Dial Transplant (2013) 0.83

[Position statements regarding usage of biosimilars of Epoetins. Position paper of the Société de néphrologie, Société francophone de dialyse, and Société de néphrologie pédiatrique]. Nephrol Ther (2008) 0.83

International Study of Health Care Organization and Financing for end-stage renal disease in France. Int J Health Care Finance Econ (2007) 0.83

Low amounts of trans 18:1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defence to oxidative stress in mice. Br J Nutr (2005) 0.82

Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype. Antimicrob Agents Chemother (2010) 0.82

Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus. Expert Opin Pharmacother (2010) 0.82

Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes. Br J Clin Pharmacol (2011) 0.82

Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus. J Antimicrob Chemother (2007) 0.81

Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonates. Neonatology (2006) 0.81

Alterations in cytoskeletal protein expression by mycophenolic acid in human mesangial cells requires Rac inactivation. Biochem Pharmacol (2006) 0.81

Pravastatin in HIV-infected patients treated with protease inhibitors: a placebo-controlled randomized study. HIV Clin Trials (2007) 0.81

Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study. BMC Nephrol (2013) 0.80

[Evolution of the diet from the paleolithic to today: progress or regress?]. Nephrol Ther (2013) 0.80

Lethal acute poisoning with potassium ferrocyanide. Am J Emerg Med (2010) 0.80